Schedule 13G ownership disclosure

AUTOLUS THERAPEUTICS LTD

Security class unavailable · CUSIP: 05280R100

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,955,806
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422849-21-000005
Form type
SC 13G
Filer
Autolus Therapeutics plc
CIK
CIK 1730463
Filed
Feb 16, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub